Dermoscopy for Surgical Planning Before Mohs Micrographic Surgery
Dermoscopy provides 10-20x magnification that reveals subclinical features of BCC, SCC, and lentigo maligna invisible to the naked eye. A 2022 systematic review and meta-analysis (PMID 36534540) found that dermoscopy-guided BCC excision significantly reduces positive lateral margin rates compared with clinical inspection alone, with one prospective series achieving 98.1% radical resection at 4 mm dermoscopy-guided margins (PMID 35818112). For Mohs surgeons, preoperative dermoscopy supports three decisions: confirming the diagnosis, marking the visible clinical margin, and identifying subclinical extension that may raise the expected stage count.
By Dr. Yehonatan Kaplan (M.D., Fellow ACMS)·Published: 2026-04-22·Updated: 2026-04-22·Reviewed: 2026-04-22
dermoscopyBCCSCCmargin delineationMohs surgerypreoperative planningtumor mappingsurgical planning
Key Takeaways
- Dermoscopy provides 10-20x magnification that reveals subclinical features invisible to the naked eye and supports three Mohs decisions: diagnosis, margin marking, and subclinical extension prediction.
- A 2022 systematic review and meta-analysis (PMID 36534540) found dermoscopy-guided BCC excision significantly reduces positive lateral margin rates versus clinical inspection alone.
- A 2022 prospective series (PMID 35818112) achieved 98.1% radical resection of primary BCC with 4 mm dermoscopy-guided margins.
- A 368-case Mohs study (PMID 34013989) found dermoscopic margin accuracy is highest for nodular BCC and lowest for infiltrative subtypes.
- For SCC, vessel morphology correlates with histologic grade (PMID 25363081): hairpin vessels in well-differentiated, atypical polymorphic vessels in poorly-differentiated tumors.
- Limitations: dermoscopy cannot detect deep extension, may underestimate margins in infiltrative BCC and DFSP, and never substitutes for biopsy when diagnosis is uncertain.
Overview: Why Dermoscopy Matters for Mohs
Dermoscopy provides 10-20x magnification of skin lesions, revealing morphologic features invisible to the naked eye. For the Mohs surgeon, dermoscopy supports three decisions: confirming the diagnosis preoperatively, mapping the clinical margin before excision, and identifying subclinical extension that may increase the expected stage count. A 2022 systematic review and meta-analysis (PMID 36534540) of dermoscopy-guided BCC excision demonstrated significantly lower positive lateral margin rates compared with clinical inspection alone. The clinical implication is direct: a few minutes spent with a polarized handheld dermatoscope before marking can convert a likely two-stage Mohs case into a single-stage clearance.
Dermoscopic Features of BCC
BCC has well-described dermoscopic patterns that vary by histologic subtype. The hallmark feature across subtypes is the absence of a pigment network combined with one or more BCC-specific criteria. Recognizing the subtype dermoscopically before surgery helps anticipate subclinical extension: infiltrative and morpheaform BCC commonly extend well beyond the dermoscopic boundary, while nodular BCC tends to correlate more closely with the visible margin.
| Subtype | Dominant Vessels | Pigmented Structures | Other Features |
|---|---|---|---|
| Nodular | Arborizing telangiectasias (thick stem, sharp focus) | Blue-grey ovoid nests, leaf-like areas | Ulceration, shiny white-red structureless areas |
| Superficial | Short fine telangiectasias (thin, poorly focused) | Maple leaf-like areas, spoke-wheel structures | Multiple small erosions, shiny white-red structureless areas |
| Pigmented | Variable arborizing or fine telangiectasias | Blue-grey ovoid nests, large blue-grey dots/globules, leaf-like, spoke-wheel | Absence of pigment network |
| Infiltrative / morpheaform | Fine telangiectasias on a pearly white background | Few or absent pigmented structures | Poorly defined borders, white-red structureless areas |
Dermoscopic Features of SCC and Precursors
Dermoscopy of squamous lesions tracks the spectrum from actinic keratosis to invasive SCC. Vessel morphology and keratinization patterns are the most useful discriminators. Per published literature (PMID 33954021), distinct dermoscopic patterns separate AK, SCC in situ, and invasive SCC by differentiation grade. A 2014 study (PMID 25363081) showed that vessel morphology correlates with SCC histologic grade: well-differentiated tumors show hairpin vessels and white halos around follicles, while poorly-differentiated tumors show predominantly atypical polymorphic and arborizing vessels with less keratin.
| Lesion | Vessels | Surface / Scale | Other Clues |
|---|---|---|---|
| Actinic keratosis | Dotted and glomerular vessels | Adherent yellow-white scale | Erythema, "strawberry pattern" on facial AK |
| SCC in situ (Bowen) | Clustered glomerular and dotted vessels | Opaque yellow-white scale | Pink or pigmented background, scaly plaque |
| Well-differentiated invasive SCC | Hairpin-like vessels with white halos | Central keratin clods, ulceration | White circles around follicular openings |
| Poorly-differentiated SCC | Atypical polymorphic and arborizing vessels | Less keratin, more bleeding | Structureless red areas, ulceration |
Dermoscopic Margin Delineation: The Evidence
A 2022 systematic review and meta-analysis (PMID 36534540) of dermoscopy-guided BCC excision found significantly lower positive lateral margin rates compared with clinical-only delineation. A 2022 prospective series demonstrated that dermoscopy-guided 4 mm excision achieved 98.1% radical resection of primary BCC (PMID 35818112). An earlier digital dermoscopy study reduced suboptimal excision to 7% versus a higher rate with clinical marking alone (PMID 22150641). For Mohs surgery specifically, a 368-case Mohs series (PMID 34013989) assessed dermoscopic accuracy for lateral margin determination across BCC subtypes, finding the highest correlation for nodular BCC and the lowest for infiltrative tumors.
| Study (PMID) | Design | Population | Key Finding |
|---|---|---|---|
| Navarrete-Dechent 2022 (36534540) | Systematic review + meta-analysis | BCC excision studies | Dermoscopy-guided excision lowered positive lateral margin rate vs clinical only |
| Jin 2022 (35818112) | Prospective comparative | Primary BCC | 98.1% radical resection with 4 mm dermoscopy-guided margin |
| Caresana 2012 (22150641) | Prospective digital dermoscopy | BCC standard excision | Suboptimal excision reduced to 7% |
| Pampin-Franco 2021 (34013989) | 368 Mohs cases | BCC subtypes | Dermoscopy accuracy highest for nodular, lower for infiltrative |
| Longo 2023 (37317762) | Ex vivo dermoscopy | Primary BCC excision | Perioperative ex vivo dermoscopy refined margin mapping |
Dermoscopy Workflow Before Mohs Surgery
A reproducible preoperative dermoscopy protocol takes 3-5 minutes per case and integrates cleanly into the standard Mohs preoperative visit. Follow this stepwise approach: 1) Photograph the lesion with both a clinical (overview) image and a dermoscopic close-up using polarized light. 2) Identify the central tumor area on dermoscopy by locating the densest cluster of BCC- or SCC-specific features. 3) Map peripheral dermoscopic features by sweeping the dermatoscope outward until classic features fade into normal skin (telangiectasias thin out, structureless areas resolve, pigmented structures disappear). 4) Mark the dermoscopically-identified clinical margin with a fine-tip surgical marking pen while the dermatoscope is still in contact. 5) Add the standard Mohs margin (typically 1-2 mm beyond the dermoscopic boundary). 6) Document the dermoscopic findings in the operative note, including the specific features identified and the size of the dermoscopic margin compared with the visible clinical margin.
Lentigo Maligna and Pigmented Lesions
Dermoscopy is essential for lentigo maligna (LM) preoperative mapping because clinical borders are notoriously poorly defined on chronically photodamaged skin. Key dermoscopic features of LM include asymmetric pigmented follicular openings, gray dots and globules, gray pseudonetwork, rhomboidal structures, an annular-granular pattern, and obliteration of follicular openings in advanced disease. Mapping with dermoscopy (and adjunctive reflectance confocal microscopy when available) supports the IDS 2026 lentigo maligna guidelines for surgical planning. Cross-reference: see the tumor-lentigo-maligna article for full LM management. For pigmented BCC, the absence of a pigment network combined with blue-grey ovoid nests or maple leaf-like structures distinguishes BCC from melanoma even when the clinical impression is ambiguous.
When Dermoscopy May Mislead the Mohs Surgeon
Dermoscopy is a powerful adjunct but has clear limitations for surgical planning. Subclinical extension can extend well beyond dermoscopic boundaries, particularly for infiltrative BCC, morpheaform BCC, and DFSP. Previously biopsied or treated lesions can have inflammation, scarring, or pigment artifact that obscures classic features. Dermoscopy cannot detect deep tumor extension because the imaging depth is limited to the papillary and upper reticular dermis. Some dermoscopic features overlap between benign and malignant lesions (see the tumor-mimickers article for BCC and SCC mimickers). Heavily pigmented patients (Fitzpatrick V-VI) require modified interpretation because background pigment can mask or alter classic patterns.
Ex Vivo Dermoscopy of Mohs Specimens
Ex vivo dermoscopy of the excised Mohs specimen can supplement frozen section evaluation. After excision, the specimen is photographed with dermoscopy and compared with the in vivo image. This helps identify areas of concern for additional sectioning when frozen sections show borderline findings, and it provides an orientation reference if the specimen needs to be re-mapped. Published evidence (PMID 37317762) demonstrates utility for standard surgical excision of primary BCC, with perioperative ex vivo dermoscopy refining margin mapping. Less data exists for routine Mohs application, but the technique is gaining adoption in practices that already use digital dermoscopy for preoperative mapping.
Dermoscopy + Reflectance Confocal Microscopy (RCM)
Reflectance confocal microscopy provides cellular-level resolution (1-3 micrometer lateral resolution) to a depth of approximately 200-300 micrometers. RCM combined with dermoscopy improves preoperative margin mapping for BCC and lentigo maligna by visualizing tumor cells beyond the limit of dermoscopic features. Published series of facial BCC margin mapping with dermoscopy plus RCM have reported improved correlation with histologic margins compared with dermoscopy alone. RCM availability is currently limited to academic centers and a small number of high-volume Mohs practices, but the evidence supports its addition to preoperative workup for poorly-defined H-zone tumors and large lentigo maligna where it is available.
Practical Recommendations
For Mohs surgeons not currently using dermoscopy preoperatively, the highest-yield steps are: 1) Use a polarized handheld dermatoscope at every preoperative visit; the equipment cost (typically under $1000) is recovered quickly through reduced positive margin rates and shorter operative times. 2) Document dermoscopic findings in the chart, including specific features identified and the dermoscopic margin compared with the visible clinical margin. 3) Mark the clinical margin based on dermoscopy before adding the standard Mohs margin. 4) For aggressive subtypes (infiltrative BCC, morpheaform BCC, DFSP), expect subclinical extension beyond the dermoscopic boundary and counsel patients about the higher likelihood of additional stages. 5) Photograph cases for personal learning and to build a reference library that improves diagnostic accuracy over time.
Frequently Asked Questions
Related Articles
Basal Cell Carcinoma: Mohs Indications & TreatmentSquamous Cell Carcinoma: Mohs Indications & TreatmentMelanoma & Mohs Surgery: Indications and Slow Mohs TechniqueLentigo Maligna: IDS 2026 Guidelines & Mohs SurgeryMohs Micrographic Surgery TechniqueBCC & SCC Mimickers: Histologic Pitfalls for Mohs Surgeons
References
- [1]Navarrete-Dechent C, Cordova M, Liopyris K, Aleissa S, Rajadhyaksha M, Cordova M, et al. The Use of Dermoscopy in the Delineation of Basal Cell Carcinoma for Mohs Micrographic Surgery: A Systematic Review With Meta-Analysis. Dermatol Surg. 2022. doi:10.1097/DSS.0000000000003670 PMID: 36534540
- [2]Rosendahl C, Cameron A, Argenziano G, Zalaudek I, Tschandl P, Kittler H. Dermatoscopy of squamous cell carcinoma and keratoacanthoma. J Eur Acad Dermatol Venereol. 2014. doi:10.1001/archdermatol.2012.1974 PMID: 25363081
- [3]Pampin-Franco A, Gamo-Villegas R, Floristan-Murúzabal U, Pinedo-Moraleda F, Pérez-Fernández E, López-Estebaranz JL. Accuracy of dermoscopy in determining the lateral margin of basal cell carcinoma subtypes treated with Mohs micrographic surgery: an analysis of 368 cases. J Eur Acad Dermatol Venereol. 2021. doi:10.1111/jdv.17376 PMID: 34013989
- [4]Jin H, Zhang Y, Yang L, Yan W, Li L, Sun Q, et al. The effect of dermoscopy in assisting on defining surgical margins of basal cell carcinoma. J Cosmet Dermatol. 2022. doi:10.1111/jocd.15146 PMID: 35818112
- [5]Caresana G, Giardini R. Dermoscopy-guided surgery in basal cell carcinoma. J Eur Acad Dermatol Venereol. 2012. doi:10.1111/j.1468-3083.2011.04313.x PMID: 22150641
- [6]Longo C, Pampena R, Lallas A, Kyrgidis A, Stratigos A, Peris K, et al. Use of preoperative and perioperative ex vivo dermoscopy for precise mapping of margins for standard surgical excision of primary basal cell carcinoma. Br J Dermatol. 2023. doi:10.1093/bjd/ljad187 PMID: 37317762
- [7]Shahriari N, Grant-Kels JM, Rabinovitz H, Oliviero M, Scope A. Dermoscopy as a Tool in Differentiating Cutaneous Squamous Cell Carcinoma From Its Mimickers. Cutis. 2021. PMID: 33954021